• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SC5b-9补体复合物β-内啡肽结合亚基的鉴定:S蛋白在与补体蛋白形成复合物时表现出特定的β-内啡肽结合位点。

Identification of the beta-endorphin-binding subunit of the SC5b-9 complement complex: S protein exhibits specific beta-endorphin-binding sites upon complex formation with complement proteins.

作者信息

Hildebrand A

机构信息

Institut für Medizinische Mikrobiologie, Justus-Liebig-Universität, Giessen, F.R.G.

出版信息

Biochem Biophys Res Commun. 1989 Mar 15;159(2):799-806. doi: 10.1016/0006-291x(89)90065-x.

DOI:10.1016/0006-291x(89)90065-x
PMID:2467672
Abstract

Beta-Endorphin has been reported to specifically interact with SC5b-9 complement complexes via non-opioid binding sites. Covalent cross-linking of [125I]beta H-endorphin to SC5b-9 and analysis of the cross-linking products by gel electrophoresis and subsequent autoradiography revealed a single specifically labelled species which was identical with the S protein subunit of the complement complex. In contrast to SC5b-9, no cross-linking of labelled beta-endorphin to subunits of C5b-9(m) could be observed, indicating that beta-endorphin binding to SC5b-9 was mediated exclusively via S protein. Beta-Endorphin binding to SC5b-9 was compared with binding to purified S protein. Whereas beta-endorphin binding to purified S protein was only modest, complex formation of S protein with complement proteins led to a strong increase in beta-endorphin-binding site concentration, compatible with the exposure of primarily cryptic beta-endorphin-binding sites on S protein.

摘要

据报道,β-内啡肽可通过非阿片类结合位点与SC5b-9补体复合物特异性相互作用。将[125I]βH-内啡肽与SC5b-9进行共价交联,并通过凝胶电泳和随后的放射自显影分析交联产物,结果显示有一个单一的特异性标记物,它与补体复合物的S蛋白亚基相同。与SC5b-9不同,未观察到标记的β-内啡肽与C5b-9(m)亚基的交联,这表明β-内啡肽与SC5b-9的结合仅通过S蛋白介导。将β-内啡肽与SC5b-9的结合与它与纯化的S蛋白的结合进行了比较。虽然β-内啡肽与纯化的S蛋白的结合程度一般,但S蛋白与补体蛋白形成复合物会导致β-内啡肽结合位点浓度大幅增加,这与S蛋白上原本隐藏的β-内啡肽结合位点的暴露情况相符。

相似文献

1
Identification of the beta-endorphin-binding subunit of the SC5b-9 complement complex: S protein exhibits specific beta-endorphin-binding sites upon complex formation with complement proteins.SC5b-9补体复合物β-内啡肽结合亚基的鉴定:S蛋白在与补体蛋白形成复合物时表现出特定的β-内啡肽结合位点。
Biochem Biophys Res Commun. 1989 Mar 15;159(2):799-806. doi: 10.1016/0006-291x(89)90065-x.
2
Beta-endorphin binding activity of SP-40,40.SP-40,40的β-内啡肽结合活性。
Biol Pharm Bull. 1993 Mar;16(3):228-31. doi: 10.1248/bpb.16.228.
3
Interaction of human beta-endorphin with the terminal SC5b-9 and "preterminal" SC5b-7 and SC5b-8 complexes of human complement.
Life Sci. 1982;31(20-21):2275-8. doi: 10.1016/0024-3205(82)90136-9.
4
Interaction of human beta-endorphin with nonopiate binding sites on the terminal SC5b-9 complex of human complement. Significance of COOH-terminal beta H-endorphin fragments.人β-内啡肽与人类补体终末SC5b-9复合物上的非阿片样结合位点的相互作用。COOH末端βH-内啡肽片段的意义。
J Biol Chem. 1983 Oct 25;258(20):12287-92.
5
SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules.补体的SC5b-7、SC5b-8和SC5b-9复合物:大分子内S蛋白(玻连蛋白)的超微结构与定位
Eur J Immunol. 1989 Jan;19(1):69-75. doi: 10.1002/eji.1830190112.
6
A novel beta-endorphin binding protein. Complement S protein (= vitronectin) exhibits specific non-opioid binding sites for beta-endorphin upon interaction with heparin or surfaces.一种新型β-内啡肽结合蛋白。补体S蛋白(=玻连蛋白)在与肝素或表面相互作用时表现出对β-内啡肽的特异性非阿片样结合位点。
J Biol Chem. 1989 Sep 15;264(26):15429-34.
7
Endotoxin-induced formation of specific beta-endorphin binding sites in human serum.内毒素诱导人血清中特异性β-内啡肽结合位点的形成。
Biochem Biophys Res Commun. 1983 Jun 29;113(3):839-44. doi: 10.1016/0006-291x(83)91075-6.
8
Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.S蛋白对补体SC5b-9复合物中C9聚合的抑制作用。
Acta Pathol Microbiol Immunol Scand Suppl. 1984;284:89-96.
9
Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.玻连蛋白介导的补体抑制作用:C5b - 7和C9不同结合位点的证据
Clin Exp Immunol. 1993 Apr;92(1):114-9. doi: 10.1111/j.1365-2249.1993.tb05956.x.
10
Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.有证据表明C5b可识别并介导C8掺入补体溶细胞复合物。
J Immunol. 1987 Sep 15;139(6):1960-4.

引用本文的文献

1
Complement inhibition by human vitronectin involves non-heparin binding domains.人玻连蛋白对补体的抑制作用涉及非肝素结合结构域。
Clin Exp Immunol. 1995 Jul;101(1):136-41. doi: 10.1111/j.1365-2249.1995.tb02289.x.
2
The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.玻连蛋白作为多功能调节因子在止血和免疫系统中的作用。
Blut. 1989 Nov;59(5):419-31. doi: 10.1007/BF00349063.